Good MorningEquity markets were flat to up on Wednesday as traders tried to gauge the future of interest rates. The S&P 500 and NASDAQ closed near break-even for the day, while the blue-chip Dow Jones Industrial Average led with a gain near 0.5%. This is the longest winning streak for the blue-chip index, putting it at a one-month high with sights on retesting the all-time high. The risk for traders now is that next week's economic data and retail sector earnings will sap sentiment and cap gains in equities.
Among the hurdles for the market is guidance. The earnings season is better than expected on average, but guidance from key companies has been light and points to a weaker 2nd half than previously forecast. In this scenario, the S&P 500 is heading toward a hard ceiling that may coincide with the next FOMC meeting. The market continues to predict an interest rate cut for this year but may be overly optimistic. The FOMC has normalized rates; we have to live with them until the next economic catastrophe.
Featured: Bitcoin Rockets To Record High But Buy THIS Instead (Paradigm Press) 
|
Markets | | | Evidence is mounting to support a bullish outlook for the agricultural sector. A closer look reveals that shares of FMC Co. (NYSE: FMC) could become one of the most attractive options within the primary industries supporting the new wave of agricultural demand. After reporting its first quarter... Read the Full Story |
|
From Our PartnersDon’t panic — you haven’t missed the boat on AI.
In fact, it has barely launched.
Sure, the early stages of this boom were big …
But I believe the real wealth in AI has yet to be made … | | | | Click here to see the presentation now. |
|
Tech | | | Lucid’s (NASDAQ: LCID) stock price has been down-trending since 2021, and it is not over. The Q1 results aren’t horrible, but they did nothing to improve the outlook for growth, market domination, or profits. The results frightened the market because spending is rising, and profitability... Read the Full Story |
|
Markets | | | Generac Holdings Inc. (NYSE: GNRC) is attempting to recover from its Q1 2024 earnings selloff. The computer and technology sector company is a leader in manufacturing backup power generators with a 70% market share. It has expanded its offerings to include a range of clean energy, battery and monito... Read the Full Story |
|
From Our PartnersToday I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months.
You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists…
It’s a revolutionary software system that tracks the moves of institutional investors…. in real time… | | | | Go here to watch the most recent trading workshop video at no charge. |
|
Markets | | | Homebuilder PulteGroup Inc. (NYSE: PHM) shares are trading up 13% year-to-date despite a soft housing market. High interest rates have led to a weak existing home sales market, where owners refuse to sell their homes only to get trapped with higher mortgage rates on their next home. 7% mortgage rate... Read the Full Story |
|
Markets | | | Congress and the Biden administration are considering what, if anything, should be done to tighten restrictions on donor-advised funds, an increasingly popular way for donors to set aside money to spend on charitable causes Read the Full Story |
|
From Our PartnersObama’s Forever Term [Exposed] or Obama Biden has already won 2024
Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future. | | | | Click here to watch this now before it’s too late. |
|
Stocks | | | Stocks in Asia were mixed Friday after a rally on Wall Street that pulled the S&P 500 back within 1% of its record. Benchmarks fell in Tokyo, Sydney and Seoul but rose in China, where investors were focused on the release of April inflation figures.In Japan, the Finance Ministry reported a recor... Read the Full Story |
|
Stocks | | | Airbnb's profit more than doubled last quarter, but management's disappointing revenue forecast sparked a roughly 7% drop in its stock in after-market trading Wednesday.The San Francisco-based vacation rental app said its net income rose to $264 million in the first quarter from $117 million a year ... Read the Full Story |
|
Markets | | | Plant-based meat maker Beyond Meat urged investors to look past its mixed first quarter results Wednesday, saying a new, healthier burger hitting U.S. shelves now will help reignite weak sales.“We really do believe we are at the early stages of a pivotal and terrific year for Beyond Meat,” President... Read the Full Story |
|
Markets | | | Prices in Argentina have surged so dramatically in recent months that the government has multiplied the size of its biggest bank note in circulation by five — to 10,000 pesos, worth about $10. The central bank announcement Tuesday promised to lighten the load for many Argentines who must carry aroun... Read the Full Story |
|
Markets | | | Earnings reports are trickling out from some of the biggest public companies, and investors remain uncertain about the current environment. Economic expansion is slowing and sentiment is muted, but good earnings data could boost stocks into the next leg of the bull market. Are you up to speed on how... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax vaccine; CYFENDUS for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; and Raxibacumab injection for the treatment and prophylaxis of inhalational anthrax. It also provides ACAM2000, a smallpox vaccine; CNJ-016 to address complications from smallpox vaccination; TEMBEXA for the treatment of smallpox disease caused by variola virus in adult and pediatric patients; BAT for the treatment of symptomatic botulism; Ebanga for the treatment of Ebola; Reactive Skin Decontamination Lotion Kit to remove or neutralize chemical warfare agents from the skin; Trobigard, a atropine sulfate obidoxime chloride auto-injector. In addition, the company is developing CGRD-001 for the treatment of poisoning by organophosphorus nerve agents or organophosphorus compounds; EBS-LASV to prevent Lassa fever; EBS-MARV to prevent Marburg virus disease; EBS-SUDV to prevent Sudan virus disease; Pan-Ebola mAbs for the treatment of ebola virus; SIAN Antidote for initial treatment of certain or suspected acute cyanide poisoning; UniFlu for immunity against influenza A and B viruses; and WEVEE-VLP for equine encephalitis virus infections. Further, it provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland. | | View Today's Stock Pick |
|
